{
  "docId": "019de513-bbaf-7632-8c51-2e65d00dc762",
  "docSlug": "d61504792622527e2ff1c803565a1f5e",
  "documentTitle": "Bausch+Lomb | Results Presentation Deck | 42 slides",
  "authorId": "bausch-lomb",
  "authorName": "Bausch + Lomb",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 30,
  "pageCount": 42,
  "prevPage": 29,
  "nextPage": 31,
  "slideType": "revenue_buildup",
  "function": "decompose_segments",
  "density": "dense",
  "nDataPoints": 50,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de513-bbaf-7632-8c51-2e65d00dc762/30",
  "deckHref": "/decks/019de513-bbaf-7632-8c51-2e65d00dc762",
  "deckJsonHref": "/decks/019de513-bbaf-7632-8c51-2e65d00dc762.json",
  "deckAnchorHref": "/decks/019de513-bbaf-7632-8c51-2e65d00dc762#slide-30",
  "components": [
    {
      "bbox": {
        "h": 0.02,
        "w": 0.09,
        "x": 0.04,
        "y": 0.94
      },
      "kind": "image",
      "text": "BAUSCH+LOMB",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bfc45163-7253-4d2c-8674-c8d925a79d6e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.7,
        "x": 0.15,
        "y": 0.92
      },
      "kind": "source-note",
      "text": "1. Products with sales outside the United States impacted by F/X changes.\n2. This is a non-GAAP measure or ratio. See Slide 2 and Appendix for further information on non-GAAP measures and ratios.\n3. Includes transactional FX and NCI.\n4. On a proforma basis after giving effect to the IPO.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a464d736-ea00-4afc-a23b-68860d37c0f2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.73,
        "w": 0.89,
        "x": 0.05,
        "y": 0.14
      },
      "kind": "table",
      "text": "Bausch + Lomb 2Q22-1Q22 2Q21-1Q21 Reported Change Constant Currency³ Organic Change³ Vision Care Revenue $1,149M $1,112M 3% 8% 8% Surgical Revenue $358M $347M 3% 8% 10% Ophthalmic Pharmaceuticals Revenue $323M $356M (9%) (6%) (6%) Total Revenue $1,830M $1,815M 1% 5% 5% Adj. Gross Profit² $1,103M $1,115M (1%) 2% Adj. Gross Margin² 60.3% 61.4% (110 bps) R&D $152M $138M (10%) (13%) R&D percent of Revenues 8.3% 7.6% Adj. SG&A² $700M $668M (5%) (9%) Adj. SG&A percent of Revenues² 38.3% 36.8% Adj. EBITA² $251M $309M (19%) (16%) Depreciation $64M $64M 0% 5% Stock Based Compensation $27M $29M (7%) (7%) Adj. EBITDA 2,3 $352M $398M (12%) (14%) Adj. EBITDA Margin² 19.2% 21.9% Adj. Net Income³ $188M $209M (10%) (13%) Adj EPS2,4 $0.54 $0.60",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "db343992-b2b7-4e9e-abb5-90bbfd6a2dcc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.76,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "Total Bausch + Lomb P&L¹ (Non-GAAP)² - YTD",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "340d13b5-1ec4-41a6-9231-b1ff37906c78",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}